ArticleTherapeutic advances in neurological disorders2019
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature.
Article in Therapeutic advances in neurological disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Autoimmune encephalitis with Anti-mGluR1 antibodies: a comprehensive review.Journal of neurology · 2025Pooled it
- Clinical Characteristics of Japanese Cases of Anti-Metabotropic Glutamate Receptor Type 1 Antibody-Associated Cerebellar Ataxia.Cerebellum (London, England) · 2026Article
- Neuronal antibody targeting metabotropic glutamate receptor 8 in five cases and its pathogenicity.Journal of neurology · 2026Article
- Anti-mGluR encephalitis: case series and literature review.BMC neurology · 2026Review
- Clinical Phenotypes and Prognosis of Anti-mGluR1 Encephalitis: A Single-Center Case Series and Comprehensive Literature Review.Diagnostics (Basel, Switzerland) · 2026Article
- Case Report: Rare brainstem involvement in anti-metabotropic glutamate receptor 1 encephalitis.Frontiers in immunology · 2026Article
- Efficacy of early rituximab treatment in anti-mGluR1 encephalitis: a case report.BMC neurology · 2025Article
- Case Report: Clinical features and management of anti-mGluR1 encephalitis: case illustration and review of the literature.Frontiers in integrative neuroscience · 2025Article
- A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts.Neurology international · 2024Review
- Origins and immunopathogenesis of autoimmune central nervous system disorders.Nature reviews. Neurology · 2023Review
- Why immunoexcitoxicity is the basis of most neurodegenerative diseases and systemic immune activation: An analysis.Surgical neurology international · 2023Article
- The biochemical basis of neurodegenerative disease: The role of immunoexcitoxicity and ways to possibly attenuate it.Surgical neurology international · 2023Review
- Anti-mGluR1 encephalitis: Case illustration and systematic review.Frontiers in neurology · 2023Article
- Molecular mimicry between SARS-CoV-2 and human proteins.Autoimmunity reviews · 2021Article
- Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.Frontiers in immunology · 2021Review
- Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effects.Neurology(R) neuroimmunology & neuroinflammation · 2021Article
- Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.Neurology · 2020Article
- A Novel Case of Idiopathic MGluR1 Encephalitis in a Pediatric Patient.Child neurology openArticle
- Favorable Outcome with Intravenous Immunoglobulin Therapy in Late-Onset Anti-mGluR1 Encephalitis: A Case Report and Literature Review.Case reports in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1 is a rare autoimmune disease with only 18 cases being described in the literature so far. Most patients present with subacute cerebellar ataxia. In more than one third of cases a paraneoplastic aetiology has been suspected. Here we report a case of a 45-year-old man without known malignancy, who presented with progressive dysarthria and subsequently developed subacute cerebellar ataxia. Immunotherapy with glucocorticoids, i.v. immunoglobulins and rituximab improved clinical symptoms and resulted in a stable disease course up to the present. The article describes the clinical course of the patient with a follow-up-period of approximately 24 months and reviews the cases reported in the literature so far.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.